Halberd Corporation, a biotech company, develops treatments for blood-borne and neurologic diseases. It offers treatments for post-traumatic stress disorder/chronic traumatic encephalopathy, cancer, and COVID-19. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
Frequently asked questions
What sector does Tykhe Corp (HALB) operate in?
Tykhe Corp belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Tykhe Corp (HALB) current stock price?
As of the latest data, Tykhe Corp stock price is $0.00, with a previous close of $0.00.
What is Tykhe Corp (HALB) current market capitalization?
Tykhe Corp market cap is approximately 1.13 million.
Does Tykhe Corp (HALB) pay dividends?
No. Tykhe Corp does not pay a dividend.
What is Tykhe Corp (HALB) beta (volatility) score?
Tykhe Corp has a beta of 0.112, indicating lower volatility than the overall market.